Top

Published in:

01-03-2016 | My Paper 20 Years Later

Our paper 20 years later: the unfulfilled promises of nebulised adrenaline in acute severe asthma

Authors: Fekri Abroug, Fahmi Dachraoui, Lamia Ouanes-Besbes

Published in: Intensive Care Medicine | Issue 3/2016

Excerpt

Asthma is a prevalent non-communicable disease affecting around 300 million persons worldwide with an age-standardized death rate that decreased by no less than 41 % between 1990 and 2013 [1]. However, the majority of remaining asthma deaths (67 %) are deemed preventable especially in young asthmatics [2]. Childhood asthma has indeed become more frequent and severe. Preventable asthma mortality is related to poor adherence to treatment, inadequate assessment of asthma severity and that of ongoing attacks leading to implementing non-appropriate treatment [3]. …

Available only for authorised users

GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet 385:117–171CrossRef

Anagnostou K, Harrison B, Iles R, Nasser S (2012) Risk factors for childhood asthma deaths from the UK eastern region confidential enquiry 2001–2006. Prim Care Respir J 21:71–77CrossRef

Soto-Campos JG, Plaza V, Soriano JB, Cabrera-Lopez C, Almonacid-Sanchez C, Vazquez-Oliva R, Serrano J, Ballaz-Quincoces A, Padilla-Galo A, Santos V (2013) Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study. BMC Pulm Med 13:73CrossRef

Custovic A, Johnston SL, Pavord I, Gaga M, Fabbri L, Bel EH, Le Souef P, Lotvall J, Demoly P, Akdis CA, Ryan D, Makela MJ, Martinez F, Holloway JW, Saglani S, O’Byrne P, Papi A, Sergejeva S, Magnan A, Del Giacco S, Kalayci O, Hamelmann E, Papadopoulos NG (2013) EAACI position statement on asthma exacerbations and severe asthma. Allergy 68:1520–1531CrossRef

Salmeron S, Brochard L, Mal H, Tenaillon A, Henry-Amar M, Renon D, Duroux P, Simonneau G (1994) Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med 149:1466–1470CrossRef

Rowe BH, Sevcik W, Villa-Roel C (2011) Management of severe acute asthma in the emergency department. Curr Opin Crit Care 17:335–341CrossRef

Hanania NA, Dickey BF, Bond RA (2010) Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med 16:1–5CrossRef

Hanania NA, Sharafkhaneh A, Barber R, Dickey BF (2002) Beta-agonist intrinsic efficacy: measurement and clinical significance. Am J Respir Crit Care Med 165:1353–1358CrossRef

Elatrous S, Elidrissi H, Trabelsi H, Boujdaria R, Boussarsar M, Ouannes L, Bouzouita K, Nouira S, Abroug MF (1997) Dose-effect of epinephrine nebulization in asthma: a comparative study versus salbutamol. Rev Pneumol Clin 53:187–191PubMed

10.

Besbes-Ouanes L, Nouira S, Elatrous S, Knani J, Boussarsar M, Abroug F (2000) Continuous versus intermittent nebulization of salbutamol in acute severe asthma: a randomized, controlled trial. Ann Emerg Med 36:198–203CrossRef

11.

Baldwin DR, Sivardeen Z, Pavord ID, Knox AJ (1994) Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo. Thorax 49:1103–1108CrossRef

12.

Becker AB, Nelson NA, Simons FE (1983) Inhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children. J Pediatr 102:465–469CrossRef

13.

Abroug F, Nouira S, Bchir A, Boujdaria R, Elatrous S, Bouchoucha S (1995) A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma. Intensive Care Med 21:18–23CrossRef

14.

Coupe MO, Guly U, Brown E, Barnes PJ (1987) Nebulised adrenaline in acute severe asthma: comparison with salbutamol. Eur J Respir Dis 71:227–232PubMed

15.

Zeggwagh AA, Abouqal R, Madani N, Abidi K, Moussaoui R, Zekraoui A, Kerkeb O (2002) Comparative efficiency of nebulized adrenaline and salbutamol in severe acute asthma. A randomized, controlled prospective study. Ann Fr Anesth Reanim 21:703–709CrossRef

16.

Adoun M, Frat JP, Dore P, Rouffineau J, Godet C, Robert R (2004) Comparison of nebulized epinephrine and terbutaline in patients with acute severe asthma: a controlled trial. J Crit Care 19:99–102CrossRef

17.

Plint AC, Osmond MH, Klassen TP (2000) The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med 7:1097–1103CrossRef

18.

Rodrigo GJ, Nannini LJ (2006) Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials. Am J emerg med 24:217–222CrossRef

Title: Our paper 20 years later: the unfulfilled promises of nebulised adrenaline in acute severe asthma
Authors: Fekri Abroug
Fahmi Dachraoui
Lamia Ouanes-Besbes
Publication date: 01-03-2016
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 3/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-016-4210-1

At a glance: The STEP trials

Springer Medicine

Our paper 20 years later: the unfulfilled promises of nebulised adrenaline in acute severe asthma

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2016

SEPsis REcognition and MAnagement (SEPREMA survey)

Lactate-guided resuscitation saves lives: no

Night shifts, human factors, and errors in the ICU: a causal pathway?

How should clinicians respond to requests for potentially inappropriate treatment?

Circulating phthalates during critical illness in children are associated with long-term attention deficit: a study of a development and a validation cohort

Erratum to: European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care